amvuttra
(VUTRISIRAN)Alnylam Pharmaceuticals, Inc.
Usage: AMVUTTRA is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.
Transthyretin-directed RNA Interaction class drugs
3 results
onpattro
(patisiran)Alnylam Pharmaceuticals, Inc.Usage: ONPATTRO is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.tegsedi
(inotersen)Akcea Therapeutics, Inc.Usage: TEGSEDI is indicated for treating the polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults.